Tenaya Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Tenaya Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- TNYA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001858848
Board of directors
-
Amy L. Burroughs · DirectorSince 2023
-
Catherine Stehman-Breen · DirectorSince 2023
-
David Goeddel V · DirectorSince 2023
-
Deepak Srivastava · DirectorSince 2023
-
Faraz Ali · Director · Chief Executive OfficerSince 2023
-
Jeffrey T. Walsh · DirectorSince 2023
-
Jin-Long Chen · DirectorSince 2023
-
June Lee · DirectorSince 2023
-
Karah Herdman Parschauer · DirectorSince 2023
-
R. Sanders Williams · DirectorSince 2023
Chief executives
Faraz Ali
· Chief Executive Officer
Dates unknown
Board connections
5 of this board's directors also sit on 6 other boards.
- via R. Sanders Williams
- via Amy L. Burroughs
- via Catherine Stehman-Breen
- via June Lee
- via Karah Herdman Parschauer
- via R. Sanders Williams
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2025 | Higa Tomohiro Officer (SVP, Finance) | Open-market sale | −1,017 | $0.54 | $549 |
| Mar 10, 2025 | Tingley Whittemore Officer (Chief Medical Officer) | Open-market sale | −1,727 | $0.54 | $933 |
| Mar 10, 2025 | Faraz Ali Director, Officer (Chief Executive Officer) | Open-market sale | −5,794 | $0.54 | $3,129 |
| Mar 10, 2025 | Higa Tomohiro Officer (SVP, Finance) | Open-market sale | −620 | $0.54 | $335 |
| Mar 10, 2025 | Tingley Whittemore Officer (Chief Medical Officer) | Open-market sale | −4,073 | $0.54 | $2,199 |
| Mar 10, 2025 | Faraz Ali Director, Officer (Chief Executive Officer) | Open-market sale | −3,947 | $0.54 | $2,131 |
| Mar 10, 2025 | Higa Tomohiro Officer (SVP, Finance) | Open-market sale | −845 | $0.54 | $456 |
| Mar 10, 2025 | Tingley Whittemore Officer (Chief Medical Officer) | Open-market sale | −1,598 | $0.54 | $863 |
| Mar 5, 2025 | COLUMN GROUP III, LP 10% owner | Open-market purchase | +35,714,284 | $0.70 | $24,999,999 |
| Mar 5, 2025 | David Goeddel V Director, 10% owner | Open-market purchase | +35,714,284 | $0.70 | $24,999,999 |
| Feb 6, 2025 | Faraz Ali Director, Officer (Chief Executive Officer) | Grant or award | +107,500 | — | — |
| Feb 6, 2025 | Faraz Ali Director, Officer (Chief Executive Officer) | Grant or award | +34,424 | — | — |
| Jan 24, 2025 | Tingley Whittemore Officer (Chief Medical Officer) | Grant or award | +40,000 | — | — |
| Jan 24, 2025 | Tingley Whittemore Officer (Chief Medical Officer) | Grant or award | +31,676 | — | — |
| Nov 18, 2024 | Saito Chihiro Officer (SVP, Accounting and Fin. Ops.) | Open-market sale | −2,258 | $2.12 | $4,787 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.